The Left eats its own: The New Yorker criticizes Elizabeth Warren for checking her ancestry, asserts that idea of biological differences among people is “pernicious”

The more I read the New Yorker, the more I realize two things. First, it’s rapidly become a sophisticated version of HuffPo, a liberal magazine marinated in Authoritarian Leftism. That became palpably clear when the editor, David Remnick, who was scheduled to interview Steve Bannon onstage at this month’s New Yorker Festival, disinvited Bannon. (Several … Continue reading The Left eats its own: The New Yorker criticizes Elizabeth Warren for checking her ancestry, asserts that idea of biological differences among people is “pernicious”

More on Mukherjee

We’ll have two guest posts today, and the second comes from Greg Mayer, who’s been AWOL for a while (he’s now in Costa Rica). by Greg Mayer As WEIT readers know, Pulitzer Prize winning author and physician Siddharta Mukherjee has been in the news since he published an article in the New Yorker on “epigenetics”. Surprisingly … Continue reading More on Mukherjee

Mukherjee corrects his new book in light of epigenetics kerfuffle, still defends his mischaracterization of gene regulation

You may remember—but not want to remember—the Big Epigenetic Kerfuffle documented on this website (see list of pieces here). It involved Siddhartha Mukherjee, doctor and Pulitzer-Prize-winning author, who was taken to the woodshed by a passel of famous molecular biologists for distorting the state of epigenetics research in a popular article. Mukherjee’s piece, “Same but different,” was … Continue reading Mukherjee corrects his new book in light of epigenetics kerfuffle, still defends his mischaracterization of gene regulation

L’Affaire Mukherjee: the last word

Barring unforseen circumstances, this will be the last post I put up about Siddhartha Mukherjee’s misleading article about epigenetics and The New Yorker (see my posts on it here and here). First, on the website of the Scripps Translational Science Institute, Mukherjee has written a rebuttal, which is not really directed at the posts on this … Continue reading L’Affaire Mukherjee: the last word

Matthew reviews Mukherjee’s new book in Nature

Siddhartha Mukherjee, Pulitzer-Prize-winning author of The Emperor of All Maladies, and subject to a bit of discussion on this site in the last week, has now published a new book: The Gene: An Intimate History, and our own Matthew Cobb has just reviewed in in Nature (free link).  The book is doing well on Amazon, … Continue reading Matthew reviews Mukherjee’s new book in Nature

The End of the Mukherjee Affair: He “clarifies” in response to a critical letter

Let’s mercifully draw the curtain on L’Affaire Mukherjee, which started when a number of eminent scientists criticized Siddhartha Mukherjee’s May 2 New Yorker piece because it gave a completely distorted view of how genes are turned on and off to make bodies (see critiques here and here). I’ve been awaiting the New Yorker‘s and Mukherjee’s response … Continue reading The End of the Mukherjee Affair: He “clarifies” in response to a critical letter

Forbes’s choice of best popular biology books of 2016

As I’m out at a meeting in Los Angeles (with a hotel room having a lovely view of the LAX runways–seriously, it’s cool: photo at bottom), I can’t really post much on science, which requires reading a paper several times and then having a lot of time to write about it. So for today’s biology fix, let me just … Continue reading Forbes’s choice of best popular biology books of 2016

Mukherjee takes confusing positions about epigenetics in Nature and in Forbes

Believe me, I really am tired of this affair and didn’t want to post more on Siddhartha Mukherjee and his New Yorker article, a piece that, to many scientists, distorted what we know about gene regulation (see here for background).  But I did note that I’d discuss press coverage of our disagreement, and we have some. Yesterday, two articles … Continue reading Mukherjee takes confusing positions about epigenetics in Nature and in Forbes